PATENT CLAIM ANALYSIS

Application Number: 16039813
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "006900"]

Abstract:
The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.

Claim (Index 40):
The method of  claim 34 , wherein the peptide molecule or pharmaceutically acceptable salt thereof or the pharmaceutical composition is provided to the subject in need thereof at an interval sufficient to ameliorate the condition.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.03704
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14714198', '15514983', '15614047', '14050349', '14872975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9106639195544692
- 35 USC 102 Novelty (BERT): 0.6367500749176487
- Combined Prediction Score: 0.8832725350907872
- Mean Citation Score: 845.1664359999999
- Max Citation Score: 1016.0851
- Similarity Product: 578.2003939201118

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test